ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,670,353 | +47.0% | 34,930 | +9.6% | 0.32% | +32.1% |
| Q3 2023 | $1,136,593 | -5.1% | 31,882 | +22.8% | 0.24% | +1.2% |
| Q2 2023 | $1,198,088 | +1042.2% | 25,972 | +1047.2% | 0.24% | +135.3% |
| Q4 2022 | $104,891 | +41.7% | 2,264 | +26.1% | 0.10% | +50.0% |
| Q3 2022 | $74,000 | -57.5% | 1,795 | -38.5% | 0.07% | -48.5% |
| Q2 2022 | $174,000 | +3.0% | 2,918 | +25.5% | 0.13% | +65.0% |
| Q1 2022 | $169,000 | – | 2,326 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |